More and more states are stepping into the pharmacy transparency issue. On June 2, Vermont passed compromise legislation requiring the drug makers of 15 of the most costly drugs to show cause for their high prices. And both Ohio and California have pending bills (Massachusetts’ legislative effort was rebuffed) that would require drug companies to reveal more about drug costs and how those drugs are priced. States are seeking justification from drug companies for the high prices they charge.

Also see: “10 things to know about rising compensation costs.”

Register or login for access to this item and much more

All Employee Benefit Adviser content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access